beta-lactams has been researched along with Disease, Pulmonary in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Dartois, V; Dick, T; Negatu, DA; Zimmerman, MD | 1 |
| Amitani, R; Kimoto, T; Suzuki, K; Tanaka, E; Tsuyuguchi, K | 1 |
| Devreese, K; Leus, B; Malfait, R; van den Bossche, J | 1 |
| Abidi, MH; Chandrasekar, PH; Cronin, SM; Ibrahim, RB; Shearer, CJ | 1 |
| Brause, K; Chandler, GO; Doherty, JB; Dorn, CP; Finke, PE; Hagmann, WK; Hale, JJ; Kissinger, AL; Shah, SK; Thompson, KR | 1 |
| Ashe, BM; Davies, P; Dellea, PS; Doherty, JB; Finke, PE; Fletcher, DS; Hagmann, W; Hand, KM; Mumford, RA; Osinga, DG | 1 |
| Lietman, PS | 1 |
1 trial(s) available for beta-lactams and Disease, Pulmonary
| Article | Year |
|---|---|
Pharmacokinetics of antimicrobial drugs in cystic fibrosis. Beta-lactam antibiotics.
Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Child; Clinical Trials as Topic; Cystic Fibrosis; Humans; Infant, Newborn; Lung Diseases; Respiratory Tract Infections | 1988 |
6 other study(ies) available for beta-lactams and Disease, Pulmonary
| Article | Year |
|---|---|
Strongly Bactericidal All-Oral β-Lactam Combinations for the Treatment of Mycobacterium abscessus Lung Disease.
Topics: Amoxicillin; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cefuroxime; Humans; Lactams; Lung Diseases; Microbial Sensitivity Tests; Mycobacterium abscessus | 2022 |
Successful treatment with faropenem and clarithromycin of pulmonary Mycobacterium abscessus infection.
Topics: Anti-Bacterial Agents; beta-Lactams; Clarithromycin; Drug Therapy, Combination; Humans; Lactams; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections, Nontuberculous | 2002 |
Factor V inhibitor: case report.
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Blood Coagulation Tests; Ciprofloxacin; Disease Progression; Factor V; Humans; Immunosuppressive Agents; Intracranial Hemorrhages; Lung Diseases; Male; Postoperative Complications | 2006 |
Rhodococcus equi lung infection in an allogeneic hematopoietic stem cell transplant recipient.
Topics: Actinomycetales Infections; Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Ertapenem; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Lung Diseases; Male; Middle Aged; Radiography; Rhodococcus equi; Rifampin; Transplantation, Homologous | 2008 |
Chemical, biochemical, pharmacokinetic, and biological properties of L-680,833: a potent, orally active monocyclic beta-lactam inhibitor of human polymorphonuclear leukocyte elastase.
Topics: Amino Acid Sequence; Animals; Anti-Bacterial Agents; beta-Lactams; Biological Availability; Calcimycin; Cricetinae; Fibrinogen; Hemorrhage; Humans; Lactams; Leukocyte Elastase; Lung Diseases; Macaca mulatta; Mice; Molecular Sequence Data; Molecular Structure; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Pancreatic Elastase; Peptide Fragments; Phenylacetates; Rats; Structure-Activity Relationship | 1993 |
A comparison of alpha 1-proteinase inhibitor methoxysuccinyl-Ala-Ala-Pro-Val-chloromethylketone and specific beta-lactam inhibitors in an acute model of human polymorphonuclear leukocyte elastase-induced lung hemorrhage in the hamster.
Topics: alpha 1-Antitrypsin; Amino Acid Chloromethyl Ketones; Animals; Anti-Bacterial Agents; beta-Lactams; Bronchoalveolar Lavage Fluid; Cricetinae; Disease Models, Animal; Hemorrhage; Humans; Instillation, Drug; Lung Diseases; Male; Mesocricetus; Neutrophils; Pancreatic Elastase; Thermolysin; Trachea | 1990 |